Polarean Imaging plc (AIM:POLX)
0.9250
-0.0122 (-1.32%)
May 13, 2025, 4:35 PM GMT+1
Polarean Imaging Revenue
In the year 2024, Polarean Imaging had annual revenue of $3.09M USD with 246.82% growth. Polarean Imaging had revenue of $1.12M in the half year ending June 30, 2024, with 34.27% growth.
Revenue
$3.09M
Revenue Growth
+246.82%
P/S Ratio
4.52
Revenue / Employee
$106.55K
Employees
29
Market Cap
11.17M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.09M | 2.20M | 246.82% |
Dec 31, 2023 | 890.93K | -142.08K | -13.75% |
Dec 31, 2022 | 1.03M | -152.42K | -12.86% |
Dec 31, 2021 | 1.19M | 128.66K | 12.17% |
Dec 31, 2020 | 1.06M | -1.24M | -54.08% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
Polarean Imaging News
- 11 months ago - Polarean Raises $12.6 Million in Oversubscribed Financing Round to Accelerate XENOVIEW™ Commercialization and Strategic Growth Initiatives - GlobeNewsWire
- 2 years ago - FDA Approves Polarean's XENOVIEW™ (xenon Xe 129 hyperpolarized) for use with MRI for the Evaluation of Lung Ventilation - GlobeNewsWire